A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
In cases of Alzheimer's presenile and senile dementia, Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT), respectively, we have observed, in addition to the gray matter degeneration, a lesion that has the character of an incomplete infarction confined to the white matter. It is encountered in 60% of both groups, with mild changes in two thirds and moderate or severe changes in one third. It involves the deep white matter symmetrically, tapering off toward the cortex. It is characterized by partial loss of myelin, axons, and oligodendroglial cells; mild reactive astrocytic gliosis; and sparsely distributed macrophages as well as stenosis resulting from hyaline fibrosis of arterioles and smaller vessels. No complete or cavitating infarctions and no hypertensive vascular changes were observed. The white matter changes are thought to be due to hypoperfusion of the concerned white matter territories since, in addition to the white matter hyaline vascular stenosis, these cases show signs of cardiovascular disease, usually with hypotension. The white matter disorder also occurs independent of the gray matter process of AD and SDAT and may be seen as the sole brain lesion in non‐AD subjects. Its occurrence is thus neither regularly related to the severity nor to the regional appearance and accentuation of the cortical Alzheimer process and is thus not likely to be just the result of a wallerian degeneration. Histologically it is similar in several respects to Binswanger's disease, although with some distinct differences. It is thus related to the cerebrovascular group of disorders in addition to AD and SDAT. In view of its frequency and severity, this white matter lesion is important to define, to diagnose, and ultimately to prevent or cure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“White matter degeneration and microbleeds most likely reflect direct tissue damage,71,78–80”
In the citing paper
“white matter degeneration is related to Alzheimer disease pathology78”
In the citing paper
“white matter degeneration is related to Alzheimer disease pathology78 and microbleeds to CAA.”
In the citing paper
“In Alzheimer’s disease, white matter degeneration is a frequent structural brain change apart from grey matter atrophy (Brun and Englund, 1986).”
From White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease (2018) · cites this paper as Brun and Englund, 1986
In the citing paper
“Such white matter alterations cannot be fully accounted for as degenerative processes secondary to grey matter damage (Brun and Englund, 1986; Englund, 1998; Agosta et al., 2011), but may stem from vascular amyloid deposition and microvascular damage (Weller et al., 2009).”
From White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease (2018) · cites this paper as Brun and Englund, 1986
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Lipcsey, A. (1980) · PubMed · Cited by 1,083
Walton, J. N. (1976) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(76)90157-x · Cited by 964
Distribution and fatty acid composition of phosphoglycerides in normal human brain
Svennerholm, L. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42702-6 · Cited by 639
Regional pattern of degeneration in Alzheimer's disease: neuronal loss and histopathological grading
BRUN, A., & ENGLUND, E. (1981) · Histopathology · doi:10.1111/j.1365-2559.1981.tb01818.x · Cited by 561
Self-citationDistribution of cerebral degeneration in Alzheimer's disease: A clinico-pathological study
Brun, A., & Gustafson, L. (1976) · Archiv f�r Psychiatrie und Nervenkrankheiten · doi:10.1007/bf00367450 · Cited by 397
Self-citationClinical features of subcortical arteriosclerotic encephalopathy (Binswanger disease)
Caplan, L. R., & Schoene, W. C. (1978) · Neurology · doi:10.1212/wnl.28.12.1206 · Cited by 282
Computed Tomography in the Elderly 2. Senile Dementia: Diagnosis and Functional Impairment
Jacoby, R. J., & Levy, R. (1980) · British Journal of Psychiatry · doi:10.1192/bjp.136.3.256 · Cited by 205
Goto, K., Ishii, N., & Fukasawa, H. (1981) · Radiology · doi:10.1148/radiology.141.3.7302224 · Cited by 181
OLSZEWSKI, J. (1962) · PubMed · Cited by 161
Subcortical arteriosclerotic encephalopathy: a clinical and radiological investigation.
Loizou, L. A., Kendall, B. E., & Marshall, J. (1981) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.44.4.294 · Cited by 139
Research works printed but not linked: 6
- Auff E, 1980, Contribution to the problem of presenile glial dystrophy, Neuropathology, 1, 113
- Binswanger O, 1984, Die Abgrenzung der allgemeinen progressiven Paralyse, Berl Klin Wochenschr, 31, 1103
- 1981, Editorial 1981.: Binswanger's encephalopathy, Lancet, 1, 923
- George AE, 1981, Parenchymal CT correlates of senile dementia (Alzheimer's disease): loss of grey‐white matter discriminability, AJNR, 2, 205
- Gustafson L, 1984, Proceedings of the VII World Congress of Psychiatry 1983
- Sternby NH, 1968, Atherosclerosis in a defined population, Acta Pathol Microbiol Scand Suppl, 194
Cited by
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Pantoni, L. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70104-6 · Cited by 3,405
Neurovascular regulation in the normal brain and in Alzheimer's disease
Iadecola, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1387 · Cited by 2,213
Iron, brain ageing and neurodegenerative disorders
Zecca, L., Youdim, M. B. H., Riederer, P., Connor, J. R., & Crichton, R. R. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1537 · Cited by 1,801
A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT
Wahlund, L. O., Barkhof, F., Fazekas, F., Bronge, L., Augustin, M., Sjögren, M., Wallin, A., Ader, H., Leys, D., Pantoni, L., et al. (2001) · Stroke · doi:10.1161/01.str.32.6.1318 · Cited by 1,797
15-year longitudinal study of blood pressure and dementia
Skoog, I., Nilsson, L., Persson, G., Lernfelt, B., Landahl, S., Palmertz, B., Andreasson, L.-A., Odén, A., & Svanborg, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90608-x · Cited by 1,726
Pathogenesis of Leukoaraiosis: A Review
Pantoni, L., & Garcia, J. H. (1997) · Stroke · doi:10.1161/01.str.28.3.652 · Cited by 1,225
Schmahmann, J. D., & Pandya, D. N. (2006) · doi:10.1093/acprof:oso/9780195104233.001.0001 · Cited by 1,157
Structural Brain Changes in Aging: Courses, Causes and Cognitive Consequences
Fjell, A. M., & Walhovd, K. B. (2010) · Reviews in the Neurosciences · doi:10.1515/revneuro.2010.21.3.187 · Cited by 1,074
Midlife blood pressure and dementia: the Honolulu–Asia aging study☆
Launer, L. J., Ross, G. W., Petrovitch, H., Masaki, K., Foley, D., White, L. R., & Havlik, R. J. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00096-8 · Cited by 1,008
Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease
Bartzokis, G. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.03.001 · Cited by 968
“Widespread and diffuse myelin breakdown has been reported to occur in AD subjects despite the lack of evidence of infarction, Wallerian degeneration, or white matter amyloid angiopathy [15,18,31,34,58,59,72,196] and these white matter deficits are observed at the earliest or preclinical stages of the disease [15,18,58…”
BackgroundScheltens, P., Barkhof, F., Leys, D., Pruvo, J. P., Nauta, J. J. P., Vermersch, P., Steinling, M., & Valk, J. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90041-v · Cited by 923
Aggregation of vascular risk factors and risk of incident Alzheimer disease
Luchsinger, J. A., Reitz, C., Honig, L. S., Tang, M. X., Shea, S., & Mayeux, R. (2005) · Neurology · doi:10.1212/01.wnl.0000172914.08967.dc · Cited by 790
The anatomy of mood disorders—review of structural neuroimaging studies
Soares, J. C., & Mann, J. J. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00006-6 · Cited by 760
Han, X., M. Holtzman, D., W. McKeel, D., Kelley, J., & Morris, J. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00997.x · Cited by 626
“…and neurobiochemical studies on white matter from AD subjects have demonstrated dramatic loss of myelin and axons, DNA fragmentation, and plasmalogen (a subclass of phospholipid enriched in myelin) deficiency in early stages of AD (Brun and Englund 1986; Lassmann et al. 1995; Han et al. 2001).”
BackgroundCerebral White Matter Is Highly Vulnerable to Ischemia
Pantoni, L., Garcia, J. H., & Gutierrez, J. A. (1996) · Stroke · doi:10.1161/01.str.27.9.1641 · Cited by 608
Marked loss of myelinated nerve fibers in the human brain with age
Marner, L., Nyengaard, J. R., Tang, Y., & Pakkenberg, B. (2003) · Journal of Comparative Neurology · doi:10.1002/cne.10714 · Cited by 599
Fernando, M. S., Simpson, J. E., Matthews, F., Brayne, C., Lewis, C. E., Barber, R., Kalaria, R. N., Forster, G., Esteves, F., Wharton, S. B., et al. (2006) · Stroke · doi:10.1161/01.str.0000221308.94473.14 · Cited by 587
“Control 3 ( 5 ) 9 (10) PV 6 (7) 5 (8) DSC 5 (7) 6 (8)”
Bozzali, M. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.6.742 · Cited by 568
NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury
Salter, M. G., & Fern, R. (2005) · Nature · doi:10.1038/nature04301 · Cited by 553
Pantoni, L., & Garcia, J. H. (1995) · Stroke · doi:10.1161/01.str.26.7.1293 · Cited by 538
APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes
Blanchard, J. W., Akay, L. A., Davila-Velderrain, J., von Maydell, D., Mathys, H., Davidson, S. M., Effenberger, A., Chen, C.-Y., Maner-Smith, K., Hajjar, I., et al. (2022) · Nature · doi:10.1038/s41586-022-05439-w · Cited by 496
“Our previous single-cell analysis uncovered AD-associated oligodendrocyte subpopulations, highlighting a role of myelin-related processes in AD pathogenesis 12 , consistent with reports of hypomy-elination and white-matter changes in AD 23,24 .”
BackgroundWhite matter changes in mild cognitive impairment and AD: a diffusion tensor imaging study
Medina, D., deToledo-Morrell, L., Urresta, F., Gabrieli, J. D. E., Moseley, M., Fleischman, D., Bennett, D. A., Leurgans, S., Turner, D. A., & Stebbins, G. T. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.03.026 · Cited by 492
“Introduction Mild cognitive impairment (MCI) may be a transitional tate between normal aging and Alzheimer’s disease (AD). ndividuals with amnestic MCI differ from healthy elderly in heir level of cognitive function, performing more poorly than ontrols on measures of memory.”
BackgroundZetterberg, H., Skillbäck, T., Mattsson, N., Trojanowski, J. Q., Portelius, E., Shaw, L. M., Weiner, M. W., Blennow, K., & Initiative, F. T. A. D. N. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2015.3037 · Cited by 487
Cerebral White Matter: Neuroanatomy, Clinical Neurology, and Neurobehavioral Correlates
Schmahmann, J. D., Smith, E. E., Eichler, F. S., & Filley, C. M. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1444.017 · Cited by 486
Stroke Risk Profile Predicts White Matter Hyperintensity Volume: The Framingham Study
Jeerakathil, T., Wolf, P. A., Beiser, A., Massaro, J., Seshadri, S., D’Agostino, R. B., & DeCarli, C. (2004) · Stroke · doi:10.1161/01.str.0000135226.53499.85 · Cited by 479
“Component risk factors are (1) age in years; (2) systolic blood pressure (SBP) in mm Hg; (3) use of antihypertensive medication; (4) diabetes; (5) number of cigarettes smoked per day; (6) other CVD; (7) atrial fibrillation; and (8) left ventricular hypertrophy (LVH) by electrocardiogram (EKG).”
BackgroundWhite matter aging drives microglial diversity
Safaiyan, S., Besson-Girard, S., Kaya, T., Cantuti-Castelvetri, L., Liu, L., Ji, H., Schifferer, M., Gouna, G., Usifo, F., Kannaiyan, N., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.01.027 · Cited by 477
Shults, C. W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509567103 · Cited by 476
Applications of diffusion‐weighted and diffusion tensor MRI to white matter diseases – a review
Horsfield, M. A., & Jones, D. K. (2002) · NMR in Biomedicine · doi:10.1002/nbm.787 · Cited by 468
Rose, S. E. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.4.528 · Cited by 464
Bartzokis, G., Cummings, J. L., Sultzer, D., Henderson, V. W., Nuechterlein, K. H., & Mintz, J. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.393 · Cited by 413
A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease
Sexton, C. E., Kalu, U. G., Filippini, N., Mackay, C. E., & Ebmeier, K. P. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.019 · Cited by 410
Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis
Gustafson, L. (1987) · Archives of Gerontology and Geriatrics · doi:10.1016/0167-4943(87)90022-7 · Cited by 389
Thal, D. R., Ghebremedhin, E., Orantes, M., & Wiestler, O. D. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.12.1287 · Cited by 384
“Hence, our results confirm an association between AD and CAA (7–9, 23, 32) as well as AS/LH (5, 7, 10, 16).”
BackgroundResultSaura, J., Luque, J. M., Cesura, A. M., Prada, M. D., Chan-Palay, V., Huber, G., Löffler, J., & Richards, J. G. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90311-5 · Cited by 382
The functional neuroanatomy of mood disorders
Soares, J. C., & Mann, J. J. (1997) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(97)00016-2 · Cited by 379
Connor, J. R., Snyder, B. S., Beard, J. L., Fine, R. E., & Mufson, E. J. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490310214 · Cited by 374
“Although AD has been considered primarily a neurodegenerative (gray matter) disease, recent studies including those using brain imaging techniques have shown that white matter changes in AD are more common than previously reported (Wallin et al., 1989; Brun and Englund, 1986; Englund et al., 1988; Miller et al., 1980).”
BackgroundSenile Dementia of the Binswanger Type: A Vascular Form of Dementia in the Elderly
Román, G. C. (1987) · JAMA · doi:10.1001/jama.1987.03400130096040 · Cited by 372
Brain Infarction and the Clinical Expression of Alzheimer Disease
Roman, G. C. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550020045023 · Cited by 350
Effectiveness of regional DTI measures in distinguishing Alzheimer’s disease, MCI, and normal aging
Nir, T. M., Jahanshad, N., Villalon-Reina, J. E., Toga, A. W., Jack, C. R., Weiner, M. W., & Thompson, P. M. (2013) · NeuroImage: Clinical · doi:10.1016/j.nicl.2013.07.006 · Cited by 348
“Changes in white matter neuropathology include partial loss of axons, myelin sheaths, and oligodendroglial cells (Brun and Englund, 1986; Sjobeck et al., 2005).”
Enhancing myelin renewal reverses cognitive dysfunction in a murine model of Alzheimer’s disease
Chen, J.-F., Liu, K., Hu, B., Li, R.-R., Xin, W., Chen, H., Wang, F., Chen, L., Li, R.-X., Ren, S.-Y., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.05.012 · Cited by 346
Vascular pathology in the aged human brain
Grinberg, L. T., & Thal, D. R. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0652-7 · Cited by 345
Cortes-Canteli, M., Paul, J., Norris, E. H., Bronstein, R., Ahn, H. J., Zamolodchikov, D., Bhuvanendran, S., Fenz, K. M., & Strickland, S. (2010) · Neuron · doi:10.1016/j.neuron.2010.05.014 · Cited by 339
Patterns of gliosis in alzheimer's disease and aging cerebrum
Beach, T. G., Walker, R., & McGeer, E. G. (1989) · Glia · doi:10.1002/glia.440020605 · Cited by 336
Kerner, N. A., & Roose, S. P. (2016) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.01.134 · Cited by 331
Svennerholm, L., & Gottfries, C. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62031039.x · Cited by 330
Alzheimer's disease affects limbic nuclei of the thalamus
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00305867 · Cited by 328
“The thalamus is generally considered to be only mildly involved in AD [17, 25, 40, 41].”
Small Vessel Disease and General Cognitive Function in Nondisabled Elderly: The LADIS Study
van der Flier, W. M., van Straaten, E. C. W., Barkhof, F., Verdelho, A., Madureira, S., Pantoni, L., Inzitari, D., Erkinjuntti, T., Crisby, M., Waldemar, G., et al. (2005) · Stroke · doi:10.1161/01.str.0000179092.59909.42 · Cited by 324
Meta-analysis of the Hachinski Ischemic Score in pathologically verified dementias
Moroney, J. T., Bagiella, E., Desmond, D. W., Hachinski, V. C., Mölsä, P. K., Gustafson, L., Brun, A., Fischer, P., Erkinjuntti, T., Rosen, W., et al. (1997) · Neurology · doi:10.1212/wnl.49.4.1096 · Cited by 316
Self-citationFibre-specific white matter reductions in Alzheimer’s disease and mild cognitive impairment
Mito, R., Raffelt, D., Dhollander, T., Vaughan, D. N., Tournier, J.-D., Salvado, O., Brodtmann, A., Rowe, C. C., Villemagne, V. L., & Connelly, A. (2018) · Brain · doi:10.1093/brain/awx355 · Cited by 309
Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease
de la Monte, S. M., Sohn, Y. K., & Wands, J. R. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00131-7 · Cited by 307
Stricker, N. H., Schweinsburg, B. C., Delano-Wood, L., Wierenga, C. E., Bangen, K. J., Haaland, K. Y., Frank, L. R., Salmon, D. P., & Bondi, M. W. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.11.027 · Cited by 307
Fellgiebel, A., Wille, P., Müller, M. J., Winterer, G., Scheurich, A., Vucurevic, G., Schmidt, L. G., & Stoeter, P. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000077817 · Cited by 298
Update on hypertension and Alzheimer's disease
Skoog, I., & Gustafson, D. (2006) · Neurological Research · doi:10.1179/016164106x130506 · Cited by 294
Wakita, H., Tomimoto, H., Akiguchi, I., & Kimura, J. (1994) · Acta Neuropathologica · doi:10.1007/bf00294175 · Cited by 292
Vascular Risk Factors and Leuko-Araiosis
Inzitari, D., Diaz, F., Fox, A., Hachinski, V. C., Steingart, A., Lau, C., Donald, A., Wade, J., Mulic, H., & Merskey, H. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520130034014 · Cited by 291
White matter damage in Alzheimer disease and its relationship to gray matter atrophy
Agosta, F., Pievani, M., Sala, S., Geroldi, C., Galluzzi, S., Frisoni, G. B., & Filippi, M. (2011) · Radiology · doi:10.1148/radiol.10101284 · Cited by 288
Niwa, K., Kazama, K., Younkin, L., Younkin, S. G., Carlson, G. A., & Iadecola, C. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00022.2002 · Cited by 286
de la Torre, J. C. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00111-1 · Cited by 284
White matter pathology isolates the hippocampal formation in Alzheimer's disease
Salat, D. H., Tuch, D. S., van der Kouwe, A. J. W., Greve, D. N., Pappu, V., Lee, S. Y., Hevelone, N. D., Zaleta, A. K., Growdon, J. H., Corkin, S., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.03.013 · Cited by 279
Changes in premorbid brain volume predict Alzheimer’s disease pathology
Silbert, L. C., Quinn, J. F., Moore, M. M., Corbridge, E., Ball, M. J., Murdoch, G., Sexton, G., & Kaye, J. A. (2003) · Neurology · doi:10.1212/01.wnl.0000079053.77227.14 · Cited by 279
Roher, A. E., Weiss, N., Kokjohn, T. A., Kuo, Y.-M., Kalback, W., Anthony, J., Watson, D., Luehrs, D. C., Sue, L., Walker, D., et al. (2002) · Biochemistry · doi:10.1021/bi026173d · Cited by 279
Diffusion tensor imaging in mild cognitive impairment and Alzheimerʼs disease: a review
Chua, T. C., Wen, W., Slavin, M. J., & Sachdev, P. S. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3282f4594b · Cited by 273
Bosch, B., Arenaza-Urquijo, E. M., Rami, L., Sala-Llonch, R., Junqué, C., Solé-Padullés, C., Peña-Gómez, C., Bargalló, N., Molinuevo, J. L., & Bartrés-Faz, D. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.02.004 · Cited by 272
Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease
Sparks, D. L., Hunsaker, J. C., Scheff, S. W., Kryscio, R. J., Henson, J. L., & Markesbery, W. R. (1990) · Neurobiology of Aging · doi:10.1016/0197-4580(90)90024-t · Cited by 271
Kelleher, R. J., & Soiza, R. L. (2013) · Europe PMC (PubMed Central) · Cited by 277
Why are stroke patients prone to develop dementia?
Pasquier, F., & Leys, D. (1997) · Journal of Neurology · doi:10.1007/s004150050064 · Cited by 257
Left ventricular dysfunction: a clue to cognitive impairment in older patients with heart failure
Zuccala, G., Cattel, C., Manes-Gravina, E., Di Niro, M. G., Cocchi, A., & Bernabei, R. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.4.509 · Cited by 253
Cerebral hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts
Okamoto, Y., Yamamoto, T., Kalaria, R. N., Senzaki, H., Maki, T., Hase, Y., Kitamura, A., Washida, K., Yamada, M., Ito, H., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0925-9 · Cited by 249
“Using H&E- and KB-stained slides cut coronally at the level of mid-hippocampus, parietal, and occipital lobes, we classified white matter lesions into four grades as reported previously [9, 17]: those with ‘normal’ (normal white Acta Neuropathol (2012) 123:381–394 383”
BackgroundOlichney, J. M., Hansen, L. A., Hofstetter, C. R., Grundman, M., Katzman, R., & Thal, L. J. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540310076019 · Cited by 246
Diffusion tensor imaging in Alzheimer’s disease and mild cognitive impairment.
Stebbins, G. T., & Murphy, C. M. (2009) · Behavioural Neurology · doi:10.1155/2009/915041 · Cited by 245
Park, L., Anrather, J., Zhou, P., Frys, K., Pitstick, R., Younkin, S., Carlson, G. A., & Iadecola, C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5207-04.2005 · Cited by 244
Skoog, I., Wallin, A., Fredman, P., Hesse, C., Aevarsson, O., Karlsson, I., Gottfries, C. G., & Blennow, K. (1998) · Neurology · doi:10.1212/wnl.50.4.966 · Cited by 241
Vascular pathologies and cognition in a population-based cohort of elderly people
Fernando, M. S., & Ince, P. G. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.09.004 · Cited by 239
“Firstly, studies of AD have identified variable attenuation of the centrum semioval white matter as a common copathology [13,14].”
BackgroundDoes vascular pathology contribute to Alzheimer changes?
Kalaria, R. N., Akinyemi, R., & Ihara, M. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.07.032 · Cited by 239
Steingart, A., Hachinski, V. C., Lau, C., Fox, A. J., Fox, H., Lee, D., Inzitari, D., & Merskey, H. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520130028013 · Cited by 239
Brain iron metabolism: Neurobiology and neurochemistry
Ke, Y., & Qian, Z. M. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.07.009 · Cited by 236
Emerging Concepts in Alzheimer's Disease
Vinters, H. V. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-163927 · Cited by 235
Cerebral Hypoperfusion Generates Cortical Watershed Microinfarcts in Alzheimer Disease
Suter, O.-C., Sunthorn, T., Kraftsik, R., Straubel, J., Darekar, P., Khalili, K., & Miklossy, J. (2002) · Stroke · doi:10.1161/01.str.0000024523.82311.77 · Cited by 235
Beach, T. G., Wilson, J. R., Sue, L. I., Newell, A., Poston, M., Cisneros, R., Pandya, Y., Esh, C., Connor, D. J., Sabbagh, M., et al. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0136-y · Cited by 233
Hypotension and cognitive impairment: Selective association in patients with heart failure
Zuccalà, G., Onder, G., Pedone, C., Carosella, L., Pahor, M., Bernabei, R., & Cocchi, A. (2001) · Neurology · doi:10.1212/wnl.57.11.1986 · Cited by 233
Amyloid-β Peptides Are Cytotoxic to Oligodendrocytes
Xu, J., Chen, S., Ahmed, S. H., Chen, H., Ku, G., Goldberg, M. P., & Hsu, C. Y. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-01-j0001.2001 · Cited by 230
“The observed AD pathology in white matter might be an indirect consequence of neuronal damage in gray matter, or of white matter vascular insufficiency (Brun and Englund, 1986).”
BackgroundQuantitation of cerebral atrophy in preclinical and end-stage Alzheimer’s disease
de la Monte, S. M. (1989) · Annals of Neurology · doi:10.1002/ana.410250506 · Cited by 229
Cognitive impact of COVID-19: looking beyond the short term
Miners, S., Kehoe, P. G., & Love, S. (2020) · Alzheimer's Research & Therapy · doi:10.1186/s13195-020-00744-w · Cited by 226
The case described by Alois Alzheimer in 1911
Möller, H.-J., & Graeber, M. B. (1998) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060050027 · Cited by 224
Takahashi, S., Yonezawa, H., Takahashi, J., Kudo, M., Inoue, T., & Tohgi, H. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00914-x · Cited by 224
Huang, J., Friedland, R. P., & Auchus, A. P. (2007) · American Journal of Neuroradiology · doi:10.3174/ajnr.a0700 · Cited by 224
Emerging Concepts in Vascular Dementia: A Review
Bir, S. C., Khan, M. W., Javalkar, V., Toledo, E. G., & Kelley, R. E. (2021) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2021.105864 · Cited by 223
Thal, D. R., Grinberg, L. T., & Attems, J. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.05.023 · Cited by 222
Consensus statement for diagnosis of subcortical small vessel disease
Rosenberg, G. A., Wallin, A., Wardlaw, J. M., Markus, H. S., Montaner, J., Wolfson, L., Iadecola, C., Zlokovic, B. V., Joutel, A., Dichgans, M., et al. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.172 · Cited by 221
Mixed Dementia—the Most Common Cause of Dementia
KORCZYN, A. D. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04807.x · Cited by 219
Amlien, I. K., & Fjell, A. M. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.02.017 · Cited by 219
Pathophysiology of Age-Related Cerebral White Matter Changes
Pantoni, L. (2002) · Cerebrovascular Diseases · doi:10.1159/000049143 · Cited by 219
Stahl, R., Dietrich, O., Teipel, S. J., Hampel, H., Reiser, M. F., & Schoenberg, S. O. (2007) · Radiology · doi:10.1148/radiol.2432051714 · Cited by 216
Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia.
Román, G. C., & Kalaria, R. N. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.10.004 · Cited by 213
Neuropathology of white matter changes in Alzheimer’s disease and vascular dementia
Englund, E. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051183 · Cited by 213
Self-citationChoo, I. H., Lee, D. Y., Oh, J. S., Lee, J. S., Lee, D. S., Song, I. C., Youn, J. C., Kim, S. G., Kim, K. W., Jhoo, J. H., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.06.015 · Cited by 211
Mielke, M. M., Okonkwo, O. C., Oishi, K., Mori, S., Tighe, S., Miller, M. I., Ceritoglu, C., Brown, T., Albert, M., & Lyketsos, C. G. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.05.2416 · Cited by 211
Diffusion tensor imaging in early Alzheimer's disease
Naggara, O., Oppenheim, C., Rieu, D., Raoux, N., Rodrigo, S., Dalla Barba, G., & Meder, J.-F. (2006) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2006.01.005 · Cited by 210
Age-related degeneration of corpus callosum measured with diffusion tensor imaging
Ota, M., Obata, T., Akine, Y., Ito, H., Ikehira, H., Asada, T., & Suhara, T. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.02.008 · Cited by 209
Metadata
- Authors
- Brun, A., & Englund, E.
- Affiliations
- Skåne University Hospital (SE)
- Corresponding author
- Brun, A.
- ORCID
- Englund, E.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1986-03
- Volume
- 19
- Issue
- 3
- Pages
- 253-262
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2017159332
- Cited by
- 1,014
- References
- 34
- Citations by year
- 2026: 8 · 2025: 16 · 2024: 15 · 2023: 25 · 2022: 19 · 2021: 14 · 2020: 18 · 2019: 21 · 2018: 24 · 2017: 22 · 2016: 22 · 2015: 23 · 2014: 37 · 2013: 33 · 2012: 30
- FWCI
- 26.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Cerebrovascular and genetic disorders
- Keywords
- Alzheimer's disease, senile dementia of the Alzheimer type, white matter disease, deep white matter, demyelination, oligodendrocyte loss, astrocytic gliosis, cerebral hypoperfusion, cardiovascular disease, Binswanger disease, cerebrovascular disease, Wallerian degeneration
- MeSH terms
- Aged, Alzheimer Disease, Brain, Cardiovascular Diseases, Cerebral Infarction, Dementia, Humans, Middle Aged, Periaqueductal Gray, Severity of Illness Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.